Dog · Canis lupus familiaris · typical adult weight 2.00–80.00 kg
Besifloxacin Ophthalmic is used in dogs for Bacterial conjunctivitis / keratitis. Routes documented in dogs: Ophthalmic. A typical adult dog weighs 2.00–80.00 kg. ExoticRx lists 1 cited dose rule for Besifloxacin Ophthalmic in dogs, drawn from published veterinary references. Verify against current literature before clinical use.
US trade names: Besivance
| Route | Dose | Frequency | Duration | Indication | Evidence | Source |
|---|---|---|---|---|---|---|
| Ophthalmic | Broad-spectrum including MRSA/MRSP | 1 drop affected eye q8h | 5-7 days | Bacterial conjunctivitis / keratitis | Moderate | Verified against Plumb's Veterinary Drug Handbook, 10th Ed, p.1374 (2026-08-01). |
Need the exact dose for your patient?
These ranges are per kg. Enter your dog's weight to get the precise dose and draw-up volume — unit and concentration math done for you.
8-chloro fluoroquinolone that inhibits both DNA gyrase and topoisomerase IV with balanced dual-targeting activity. Developed exclusively for topical ophthalmic use.
Good activity against resistant staphylococci. No systemic formulation exists, reducing resistance selection pressure. May cause transient conjunctival irritation.
Species-specific contraindications and adverse-reaction reports for dogs may differ from canine / feline reference data — consult the primary citations listed with each rule.
Besifloxacin Ophthalmic dose range in dogs, with cited source references: Ophthalmic Broad-spectrum including MRSA/MRSP 1 drop affected eye q8h. Reference ranges from cited sources — verify against current literature before clinical use.
Documented routes for Besifloxacin Ophthalmic in dogs: Ophthalmic.
Cited course lengths for Besifloxacin Ophthalmic in dogs include: 5-7 days. Duration depends on the indication — match it to the specific dose rule in the table above.
Besifloxacin Ophthalmic is indicated in dogs for: Bacterial conjunctivitis / keratitis.
These are general warnings for Besifloxacin Ophthalmic across species; consult the dog dosing table above for species-specific guidance. Good activity against resistant staphylococci. No systemic formulation exists, reducing resistance selection pressure. May cause transient conjunctival irritation.
Why a species-specific page? Besifloxacin Ophthalmic pharmacokinetics differ across species: dose ranges, intervals, and route preferences are not interchangeable. Cross-extrapolation from canine doses is unsafe in dogs — the rules above are the citations specific to this species, not generic recommendations.
Sourced from published veterinary references; awaiting credentialed clinical reviewer. See our editorial process. Reference only — not veterinary advice.